SS
Sanjay Shaileshbhai Majmudar IN IN · SEBI (PIT + SAST)
Explore the detailed record of transactions filed by Sanjay Shaileshbhai Majmudar. Officer active across 1 companies, notably Senores Pharmaceuticals Limited. Cumulatively, 24 disclosures have been published. The latest transaction was filed on 13 February 2025 — Purchase. Regulator: SEBI (PIT + SAST). The full history is accessible without signup.
Declarations 24 total
€61 10 shares @ €6.1112
Equity Shares
SEBI:ca7dc4f831de3be8c0ed130e7fabe3e2286ed634 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €108 18 shares @ €6.0048
Equity Shares
SEBI:18c93de41c6852893508743ecead9b6d98bb623d · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €6 1 shares @ €6.0957
Equity Shares
SEBI:fc62703a6552bcda9aac6ade1b24e96d234d63c6 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €275 45 shares @ €6.1073
Equity Shares
SEBI:dad55028da7063045f64281323c808e11c4fc296 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €6 1 shares @ €5.9961
Equity Shares
SEBI:abc3ea7987446220d23a8d2a66c299a8ed0336f4 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €1,938 317 shares @ €6.1123
Equity Shares
SEBI:f7aadc7cc7929a8130bc2d3d2973e9f31a0e0519 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €2,432 398 shares @ €6.1118
Equity Shares
SEBI:9b35007fc1c077f1591ceb0f0d8e514df3d47a35 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €373 61 shares @ €6.1084
Equity Shares
SEBI:3d30cb3703e8109a64f059140f77de62c58f3233 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €348 58 shares @ €6.0066
Equity Shares
SEBI:8584d79e84c021433c5541bd5640cc3f5475cd25 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €192 32 shares @ €6.0058
Equity Shares
SEBI:c7499179c2cac4aaf70f8f155291419f0d3f3cb9 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €6 1 shares @ €5.9961
Equity Shares
SEBI:3d0ba65e19a5fb5dca9b17829b05d6c80b5383a9 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €397 65 shares @ €6.109
Equity Shares
SEBI:d292d9e529f7893e2cc0b7340dcf6e763fd375bb · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €501 82 shares @ €6.1095
Equity Shares
SEBI:f393bc3a7b4c6bc5f683c683fd834c69052c7a6a · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €1,100 180 shares @ €6.1101
Equity Shares
SEBI:f7a3e8dbe696ce74777a05a046f9709cdf4598b2 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €232 38 shares @ €6.1106
Equity Shares
SEBI:7c7f6d714a9f400041225564fd73e0b0e9ce41c0 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €2,775 454 shares @ €6.1123
Equity Shares
SEBI:83c22e904a9ce2800d43efb7990c39950a29f635 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €2,247 368 shares @ €6.1062
Equity Shares
SEBI:72e5e54ec5f128c07e9df770fada2a46f9c3c9b8 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €910 149 shares @ €6.1057
Equity Shares
SEBI:556c325e9c0400a610ff8b2b624538bd06ba6145 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €795 130 shares @ €6.1123
Equity Shares
SEBI:1f16cbe0b4fb2d053eebaf8109b568b7ac78de1c · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €3,166 527 shares @ €6.0072
Equity Shares
SEBI:c56b9507bd23829f60f905731c1790a031cda935 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €228 38 shares @ €6.0055
Equity Shares
SEBI:c359caa084724f594a4901848ff94a5042f31bce · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €140 23 shares @ €6.1068
Equity Shares
SEBI:2f3944698d8ae48e25b5f9545b1940c93dcd07ac · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €6 1 shares @ €5.9961
Equity Shares
SEBI:2f71b0009cb1fd0f52ab68f71066d60092b99f06 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) €18 3 shares @ €6.0035
Equity Shares
SEBI:87d84bd128b05f626d67afea621be0472033cd78 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270)